ArticleNature communications2019

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.

Thanos P Mourikis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.